Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

574 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2).
Seifert R, Emmett L, Rowe SP, Herrmann K, Hadaschik B, Calais J, Giesel FL, Reiter R, Maurer T, Heck M, Gafita A, Morris MJ, Fanti S, Weber WA, Hope TA, Hofman MS, Fendler WP, Eiber M. Seifert R, et al. Among authors: heck m. Eur Urol. 2023 May;83(5):405-412. doi: 10.1016/j.eururo.2023.02.002. Epub 2023 Mar 17. Eur Urol. 2023. PMID: 36935345 Free article. Review.
Detection of circulating tumor cells in different stages of prostate cancer.
Thalgott M, Rack B, Maurer T, Souvatzoglou M, Eiber M, Kreß V, Heck MM, Andergassen U, Nawroth R, Gschwend JE, Retz M. Thalgott M, et al. Among authors: heck mm. J Cancer Res Clin Oncol. 2013 May;139(5):755-63. doi: 10.1007/s00432-013-1377-5. Epub 2013 Jan 29. J Cancer Res Clin Oncol. 2013. PMID: 23358719
Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM, Retz M, Bandur M, Souchay M, Vitzthum E, Weirich G, Mollenhauer M, Schuster T, Autenrieth M, Kübler H, Maurer T, Thalgott M, Herkommer K, Gschwend JE, Nawroth R. Heck MM, et al. Eur Urol. 2014 Aug;66(2):222-9. doi: 10.1016/j.eururo.2013.02.007. Epub 2013 Feb 18. Eur Urol. 2014. PMID: 23465520
Prospective comparison of computed tomography, diffusion-weighted magnetic resonance imaging and [11C]choline positron emission tomography/computed tomography for preoperative lymph node staging in prostate cancer patients.
Heck MM, Souvatzoglou M, Retz M, Nawroth R, Kübler H, Maurer T, Thalgott M, Gramer BM, Weirich G, Rondak IC, Rummeny EJ, Schwaiger M, Gschwend JE, Krause B, Eiber M. Heck MM, et al. Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):694-701. doi: 10.1007/s00259-013-2634-1. Epub 2013 Dec 3. Eur J Nucl Med Mol Imaging. 2014. PMID: 24297503
Long-term results of a phase II study with neoadjuvant docetaxel chemotherapy and complete androgen blockade in locally advanced and high-risk prostate cancer.
Thalgott M, Horn T, Heck MM, Maurer T, Eiber M, Retz M, Autenrieth M, Herkommer K, Krause BJ, Gschwend JE, Treiber U, Kübler HR. Thalgott M, et al. Among authors: heck mm. J Hematol Oncol. 2014 Mar 5;7:20. doi: 10.1186/1756-8722-7-20. J Hematol Oncol. 2014. PMID: 24598155 Free PMC article. Clinical Trial.
Categorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patients.
Thalgott M, Rack B, Eiber M, Souvatzoglou M, Heck MM, Kronester C, Andergassen U, Kehl V, Krause BJ, Gschwend JE, Retz M, Nawroth R. Thalgott M, et al. Among authors: heck mm. BMC Cancer. 2015 Jun 9;15:458. doi: 10.1186/s12885-015-1478-4. BMC Cancer. 2015. PMID: 26051431 Free PMC article. Clinical Trial.
574 results